Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia
RNA-seq (gene expression) · human · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Acute myeloid leukemiaThis series is part of our curated briefing on it.
- Samples
- 24 samples: 24 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE301645_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1285887 and SRA study SRP598095. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 24 sample titles: 24 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9086869 A1-Molm14-DMSO-R1
- GSM9086870 A2-Molm14-DMSO-R2
- GSM9086871 A3-Molm14-DMSO-R3
- GSM9086872 A4-Molm14-DMSO-R4
- GSM9086873 B1-Molm14-RMC7977-2h-R1
- GSM9086874 B2-Molm14-RMC7977-2h-R2
- GSM9086875 B3-Molm14-RMC7977-2h-R3
- GSM9086876 B4-Molm14-RMC7977-2h-R4
- GSM9086877 C1-Molm14-RMC7977-24h-R1
- GSM9086878 C2-Molm14-RMC7977-24h-R2
- GSM9086879 C3-Molm14-RMC7977-24h-R3
- GSM9086880 C4-Molm14-RMC7977-24h-R4
- GSM9086881 D1-OCIAML3-DMSO-R1
- GSM9086882 D2-OCIAML3-DMSO-R2
- GSM9086883 D3-OCIAML3-DMSO-R3
- GSM9086884 D4-OCIAML3-DMSO-R4
- GSM9086885 E1-OCIAML3-RMC7977-2h-R1
- GSM9086886 E2-OCIAML3-RMC7977-2h-R2
- GSM9086887 E3-OCIAML3-RMC7977-2h-R3
- GSM9086888 E4-OCIAML3-RMC7977-2h-R4
- GSM9086889 F1-OCIAML3-RMC7977-24h-R1
- GSM9086890 F2-OCIAML3-RMC7977-24h-R2
- GSM9086891 F3-OCIAML3-RMC7977-24h-R3
- GSM9086892 F4-OCIAML3-RMC7977-24h-R4
- GSE303795 Halofuginone exerts broad-spectrum cytotoxic effects by regulating p-eIF2α-S100A8/A9-calcium signaling, inhibiting global protein synthesis, and reversing the resistance of idarubicin in acute myeloid leukemia 6 samples same disease briefing · shares resistance
- GSE137851 The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia 387 samples same disease briefing
- GSE270185 Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia 249 samples same disease briefing
- GSE137574 Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells 24 samples same disease briefing
- GSE129437 Genome-wde mapping of BRD9 binding sites and gene expression changes upon BRD9 knockdown 6 samples same disease briefing
- GSE122515 Bonn Dataset 3 of meta-analysis on AML classification, RNAseq dataset 0 samples same disease briefing
- GSE324062 RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance 61 samples shares flt3, bcl2, ras, resistance
- GSE241650 Pharmaceutical inhibition of RAS overcomes cytokine mediated resistance to FLT3 inhibition in FLT3-ITD+ AML 76 samples shares flt3, ras, inhibition, resistance
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.